Literature DB >> 21543195

Mimicking the fibrinolytic system on material surfaces.

Dan Li1, Hong Chen, John L Brash.   

Abstract

Clotting and thrombosis remain the most serious problems in the development of blood contacting devices such as heart valves, vascular stents, grafts and catheters. No material exists that does not provoke these phenomena and coagulation appears to be inevitable when a foreign (i.e. non-endothelial) surface is in contact with blood. As an alternative to a surface that prevents coagulation, the concept of a clot-lysing or fibrinolytic surface is attractive. By designing the surface effectively to mimic the fibrinolytic system in the vasculature, it may be possible for clots to be lysed (effectively dissolved) as they form. In this review we elaborate on this concept and discuss ways in which such a surface could be realized. Developments in this area to the present time are reviewed, and some perspectives for future research are presented.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543195     DOI: 10.1016/j.colsurfb.2011.04.003

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  3 in total

Review 1.  The blood compatibility challenge. Part 2: Protein adsorption phenomena governing blood reactivity.

Authors:  John L Brash; Thomas A Horbett; Robert A Latour; Pentti Tengvall
Journal:  Acta Biomater       Date:  2019-06-18       Impact factor: 8.947

2.  A Novel Marine Pyran-Isoindolone Compound Enhances Fibrin Lysis Mediated by Single-Chain Urokinase-Type Plasminogen Activator.

Authors:  Chunli Gao; Simin Tang; Haixing Zhang; Huishu Zhang; Tian Zhang; Bin Bao; Yuping Zhu; Wenhui Wu
Journal:  Mar Drugs       Date:  2022-07-30       Impact factor: 6.085

Review 3.  Control of Blood Coagulation by Hemocompatible Material Surfaces-A Review.

Authors:  Janna Kuchinka; Christian Willems; Dmitry V Telyshev; Thomas Groth
Journal:  Bioengineering (Basel)       Date:  2021-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.